A lipidszintcsökkentó terápia helye a myocardialis infarctust követó szekunder prevencióban.

Translated title of the contribution: Lipid lowering treatment in secondary prevention following myocardial infarct

G. Paragh, Z. Balogh, J. Boda, A. Mohácsi, P. Kovács, P. Polgár, F. Wórum, G. Kakuk

Research output: Contribution to journalArticle

Abstract

1081 patients treated with myocardial infarction between 1990-1995 were investigated retrospectively, 652 (60.3%) of the patients were male and 429 (39.7%) were female. 154 (14.2%) patients had an early, while 927 (85.5%) patients had late myocardial infarction. Of the patients with early myocardial infarction 52.3% were smokers, 45.2% had positive family history for ischaemic heart disease or acute myocardial infarction. The lipid parameters were analysed in detail, because 83.3% of the patients were hyperlipoproteinaemic. The mean cholesterol level was 6.91 +/- 1.2 mmol/l, the HDL-C level was 1.19 +/- 0.38 mmol/l, the triglyceride level was 2.66 +/- 1.8 mmol/l, the LDL-C level was 4.71 +/- 1.2 mmol/l. The serum LDL-C and the HDL-C levels of the patients with early myocardial infarction were compared to the desirable levels suggested for secondary prevention. Only 7.2% of the male patients had a cholesterol level below 5.2 mmol/l, while all female patients cholesterol levels were above 5.2 mmol/l. Of the male patients 53.6%, while 78.6% of females had lower triglyceride levels than 2.3 mmol/l 78,6% of the male patients had higher protective HDL-C level in the optimal range (> 1.1 mmol/l). 12.5 percent of the male patients had an LDL-C level lower than the value targeted by secondary prevention (3.0 mmol/l), while all of the female patients LDL-C levels were higher. The authors emphasize the importance of secondary prevention and a more widespread use of lipid lowering treatment for patients after acute myocardial infarction.

Original languageHungarian
Pages (from-to)1849-1853
Number of pages5
JournalOrvosi Hetilap
Volume138
Issue number29
Publication statusPublished - Jul 20 1997

Fingerprint

Secondary Prevention
Myocardial Infarction
Lipids
Therapeutics
Cholesterol
Triglycerides
Myocardial Ischemia

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Paragh, G., Balogh, Z., Boda, J., Mohácsi, A., Kovács, P., Polgár, P., ... Kakuk, G. (1997). A lipidszintcsökkentó terápia helye a myocardialis infarctust követó szekunder prevencióban. Orvosi Hetilap, 138(29), 1849-1853.

A lipidszintcsökkentó terápia helye a myocardialis infarctust követó szekunder prevencióban. / Paragh, G.; Balogh, Z.; Boda, J.; Mohácsi, A.; Kovács, P.; Polgár, P.; Wórum, F.; Kakuk, G.

In: Orvosi Hetilap, Vol. 138, No. 29, 20.07.1997, p. 1849-1853.

Research output: Contribution to journalArticle

Paragh, G, Balogh, Z, Boda, J, Mohácsi, A, Kovács, P, Polgár, P, Wórum, F & Kakuk, G 1997, 'A lipidszintcsökkentó terápia helye a myocardialis infarctust követó szekunder prevencióban.', Orvosi Hetilap, vol. 138, no. 29, pp. 1849-1853.
Paragh G, Balogh Z, Boda J, Mohácsi A, Kovács P, Polgár P et al. A lipidszintcsökkentó terápia helye a myocardialis infarctust követó szekunder prevencióban. Orvosi Hetilap. 1997 Jul 20;138(29):1849-1853.
Paragh, G. ; Balogh, Z. ; Boda, J. ; Mohácsi, A. ; Kovács, P. ; Polgár, P. ; Wórum, F. ; Kakuk, G. / A lipidszintcsökkentó terápia helye a myocardialis infarctust követó szekunder prevencióban. In: Orvosi Hetilap. 1997 ; Vol. 138, No. 29. pp. 1849-1853.
@article{fab789ebaa8649e594a33fd795c18a90,
title = "A lipidszintcs{\"o}kkent{\'o} ter{\'a}pia helye a myocardialis infarctust k{\"o}vet{\'o} szekunder prevenci{\'o}ban.",
abstract = "1081 patients treated with myocardial infarction between 1990-1995 were investigated retrospectively, 652 (60.3{\%}) of the patients were male and 429 (39.7{\%}) were female. 154 (14.2{\%}) patients had an early, while 927 (85.5{\%}) patients had late myocardial infarction. Of the patients with early myocardial infarction 52.3{\%} were smokers, 45.2{\%} had positive family history for ischaemic heart disease or acute myocardial infarction. The lipid parameters were analysed in detail, because 83.3{\%} of the patients were hyperlipoproteinaemic. The mean cholesterol level was 6.91 +/- 1.2 mmol/l, the HDL-C level was 1.19 +/- 0.38 mmol/l, the triglyceride level was 2.66 +/- 1.8 mmol/l, the LDL-C level was 4.71 +/- 1.2 mmol/l. The serum LDL-C and the HDL-C levels of the patients with early myocardial infarction were compared to the desirable levels suggested for secondary prevention. Only 7.2{\%} of the male patients had a cholesterol level below 5.2 mmol/l, while all female patients cholesterol levels were above 5.2 mmol/l. Of the male patients 53.6{\%}, while 78.6{\%} of females had lower triglyceride levels than 2.3 mmol/l 78,6{\%} of the male patients had higher protective HDL-C level in the optimal range (> 1.1 mmol/l). 12.5 percent of the male patients had an LDL-C level lower than the value targeted by secondary prevention (3.0 mmol/l), while all of the female patients LDL-C levels were higher. The authors emphasize the importance of secondary prevention and a more widespread use of lipid lowering treatment for patients after acute myocardial infarction.",
author = "G. Paragh and Z. Balogh and J. Boda and A. Moh{\'a}csi and P. Kov{\'a}cs and P. Polg{\'a}r and F. W{\'o}rum and G. Kakuk",
year = "1997",
month = "7",
day = "20",
language = "Hungarian",
volume = "138",
pages = "1849--1853",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "29",

}

TY - JOUR

T1 - A lipidszintcsökkentó terápia helye a myocardialis infarctust követó szekunder prevencióban.

AU - Paragh, G.

AU - Balogh, Z.

AU - Boda, J.

AU - Mohácsi, A.

AU - Kovács, P.

AU - Polgár, P.

AU - Wórum, F.

AU - Kakuk, G.

PY - 1997/7/20

Y1 - 1997/7/20

N2 - 1081 patients treated with myocardial infarction between 1990-1995 were investigated retrospectively, 652 (60.3%) of the patients were male and 429 (39.7%) were female. 154 (14.2%) patients had an early, while 927 (85.5%) patients had late myocardial infarction. Of the patients with early myocardial infarction 52.3% were smokers, 45.2% had positive family history for ischaemic heart disease or acute myocardial infarction. The lipid parameters were analysed in detail, because 83.3% of the patients were hyperlipoproteinaemic. The mean cholesterol level was 6.91 +/- 1.2 mmol/l, the HDL-C level was 1.19 +/- 0.38 mmol/l, the triglyceride level was 2.66 +/- 1.8 mmol/l, the LDL-C level was 4.71 +/- 1.2 mmol/l. The serum LDL-C and the HDL-C levels of the patients with early myocardial infarction were compared to the desirable levels suggested for secondary prevention. Only 7.2% of the male patients had a cholesterol level below 5.2 mmol/l, while all female patients cholesterol levels were above 5.2 mmol/l. Of the male patients 53.6%, while 78.6% of females had lower triglyceride levels than 2.3 mmol/l 78,6% of the male patients had higher protective HDL-C level in the optimal range (> 1.1 mmol/l). 12.5 percent of the male patients had an LDL-C level lower than the value targeted by secondary prevention (3.0 mmol/l), while all of the female patients LDL-C levels were higher. The authors emphasize the importance of secondary prevention and a more widespread use of lipid lowering treatment for patients after acute myocardial infarction.

AB - 1081 patients treated with myocardial infarction between 1990-1995 were investigated retrospectively, 652 (60.3%) of the patients were male and 429 (39.7%) were female. 154 (14.2%) patients had an early, while 927 (85.5%) patients had late myocardial infarction. Of the patients with early myocardial infarction 52.3% were smokers, 45.2% had positive family history for ischaemic heart disease or acute myocardial infarction. The lipid parameters were analysed in detail, because 83.3% of the patients were hyperlipoproteinaemic. The mean cholesterol level was 6.91 +/- 1.2 mmol/l, the HDL-C level was 1.19 +/- 0.38 mmol/l, the triglyceride level was 2.66 +/- 1.8 mmol/l, the LDL-C level was 4.71 +/- 1.2 mmol/l. The serum LDL-C and the HDL-C levels of the patients with early myocardial infarction were compared to the desirable levels suggested for secondary prevention. Only 7.2% of the male patients had a cholesterol level below 5.2 mmol/l, while all female patients cholesterol levels were above 5.2 mmol/l. Of the male patients 53.6%, while 78.6% of females had lower triglyceride levels than 2.3 mmol/l 78,6% of the male patients had higher protective HDL-C level in the optimal range (> 1.1 mmol/l). 12.5 percent of the male patients had an LDL-C level lower than the value targeted by secondary prevention (3.0 mmol/l), while all of the female patients LDL-C levels were higher. The authors emphasize the importance of secondary prevention and a more widespread use of lipid lowering treatment for patients after acute myocardial infarction.

UR - http://www.scopus.com/inward/record.url?scp=0031580216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031580216&partnerID=8YFLogxK

M3 - Article

VL - 138

SP - 1849

EP - 1853

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 29

ER -